| Health / Medical Topics |
Gemfibrozil
A fibric acid derivative with hypolipidemic effects. Gemfibrozil interacts with peroxisome proliferator-activated receptors (PPARalpha) resulting in PPARalpha-mediated stimulation of fatty acid oxidation and an increase in lipoprotein lipase (LPL) synthesis. This enhances triglyceride-rich lipoprotein clearance and reduces the expression of apolipoprotein C-III (apoC-III). The reduction in hepatic production of apoC-III results in subsequent reduction of serum levels of very-low-density-lipoprotein cholesterol (VLDL-C). In addition, gemfibrozil-mediated PPARalpha stimulation of apoA-I and apoA-II expression results in an increase in high-density lipoprotein cholesterol (HDL-C). (NCI Thesaurus)
YOU MAY ALSO LIKE
A species of facultatively anaerobic, Gram positive, cocci shaped bacteria assigned to the phylum Firmicutes. This species does not form endospores, is…
A species of facultatively anaerobic, Gram positive, cocci shaped bacteria assigned to the phylum Firmicutes. This species does not form endospores, is…
A species of facultatively anaerobic, Gram positive, cocci shaped bacteria assigned to the phylum Firmicutes. This species does not form endospores, is…
A species of facultatively anaerobic, Gram positive, cocci shaped bacteria assigned to the phylum Firmicutes. This species does not form endospores, is…
A genus of facultatively anaerobic, Gram positive, cocci shaped bacterium assigned to the phylum Firmicutes and the family Bacillales XI.
A regimen consisting of gemcitabine and vinorelbine used to treat advanced-stage non-small cell lung cancer.
